Heather Scharpenseel
Koeln, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responses.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 12, 2026
Response to Trastuzumab Deruxtecan in a Patient With EGFR-Mutated NSCLC and Transformation to SCLC Harboring HER2 Amplification: A Case Report.
Journal: JTO clinical and research reports
Published: October 29, 2025
MET-Driven Resistance to Sotorasib in KRAS G12C-Mutant NSCLC and Response to Combined KRAS and MET Inhibition.
Journal: JTO clinical and research reports
Published: July 30, 2025
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 17, 2025
Advances in the targeted treatment of non-small cell lung cancer
Journal: Innere Medizin (Heidelberg, Germany)
Published: December 14, 2023
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 25, 2023
Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report.
Journal: JCO precision oncology
Published: April 20, 2023
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 06, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026